Table 1.
Baseline characteristics of participants in the DHS (data are reported as median (interquartile range) or number (%), as appropriate)
| Characteristic | Overall (n=2627) |
|---|---|
| Clinical characteristics | |
| Age (years) | 43 (36, 51) |
| Male | 1209 (46.0%) |
| Race | |
| Black | 1293 (49.2%) |
| White | 822 (31.3%) |
| Hispanic | 456 (17.4%) |
| Other | 56 (2.1%) |
| Smoking | 730 (27.8%) |
| Alcohol use | 1836 (70.0%) |
| Diabetes mellitus | 282 (10.8%) |
| Hypertension | 852 (32.9%) |
| Hyperlipidemia | 355 (13.2%) |
| Physical activity (MET-min/wk) | 145 (0, 599) |
| Family history of cancer | 583 (22.2%) |
| Biochemical characteristics | |
| High-sensitivity C-reactive protein (mg/dL) | 2.7 (1.2, 6.3) |
| Interleukin-6 (pg/mL) | 16.97 (0.0–35.76) |
| Adiponectin (ug/mL | 14.42 (9.60–21.43) |
| Leptin (ng/mL) | 11.90 (5.2, 25.3) |
| Insulin (uIU/mL) | 12.2 (7.3, 20.1) |
| Measures of adiposity | |
| Body weight (kg) | 82.10 (69.9–97.1) |
| Body mass index (kg/m2) | 29.07 (25.21, 33.93) |
| Waist circumference (cm) | 97 (87, 108.5) |
| Waist hip ratio | 0.90 (0.84–0.96) |
| Abdominal subcutaneous adipose tissue (kg) | 4.17 (2.79, 6.26) |
| Liver fat (%) | 3.60 (2.11, 6.64) |
| Lower body fat (kg) | 8.69 (6.15, 11.91) |
| Only women | (n= 1418) |
| Postmenopausal state | 488 (34.7%) |
| Oral contraceptive use | 1079 (76.3%) |
| Hormone replacement therapy use | 180 (29.5%) |